Prior to her role at the FDA, Dr. Abernethy was Chief Medical Officer, Chief Scientific Officer and Senior Vice President of Oncology of Flatiron Health, a healthcare technology and services company focused on accelerating cancer research and improving patient care that is now part of the Roche Group.
Before joining Flatiron, Dr. Abernethy was Professor of Medicine at Duke University School of Medicine and directed the Center for Learning Health Care in the Duke Clinical Research Institute and Duke Cancer Care Research Program in the Duke Cancer Institute. For more than two decades, she has pioneered the development of technology platforms to spur novel advancements in cancer care and clinical care more generally, including the development of systems by which health data can support tracking patient care, drug development, personalized medicine and scientific discovery.
Dr. Abernethy is a hematologist/oncologist and palliative medicine physician who has authored more than 500 publications. Her appointment is the latest in a series of senior executive hires at Verily, including Kerrie Peraino, Chief People Officer; Lisa Greenbaum, Chief Revenue Officer; Drew Panayiotou, Chief Marketing Officer; and Preston Simons, Chief Information Officer.
About Baseline
Verily's interdisciplinary team developed Baseline Platforms, designed to engage patients and clinicians in research, make it easier and faster to run clinical studies and collect high quality, comprehensive data for all types of clinical research including traditional clinical trials and more pragmatic real-world studies.
About Verily
Launched in 2015, Verily is a subsidiary of Alphabet focused on life sciences and healthcare. Verily's mission is to make the world’s health data useful so that people enjoy healthier lives. Verily develops tools and devices to collect, organize and activate health data, and creates interventions to prevent and manage disease. Verily partners with leading life sciences, medical device, and government organizations, using deep hardware, software, scientific, and healthcare expertise to enable faster development, meaningful advances, and deployment at scale.
Back to HCB News
